CBDBY Statistics

Total Valuation

CBDBY has a market cap or net worth of 231.06 million. The enterprise value is 1.25 billion.

Market Cap	231.06M
Enterprise Value	1.25B

Important Dates

The next estimated earnings date is Tuesday, May 6, 2025.

Earnings Date	May 6, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+65.19%
Shares Change (QoQ)	+13.92%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	399.11M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	0.97
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.06, with an EV/FCF ratio of 10.26.

EV / Earnings	-3.22
EV / Sales	0.38
EV / EBITDA	8.06
EV / EBIT	212.50
EV / FCF	10.26

Financial Position

The company has a current ratio of 0.96, with a Debt / Equity ratio of 2.91.

Current Ratio	0.96
Quick Ratio	0.59
Debt / Equity	2.91
Debt / EBITDA	10.25
Debt / FCF	11.30
Interest Coverage	-0.03

Financial Efficiency

Return on equity (ROE) is -43.49% and return on invested capital (ROIC) is -0.14%.

Return on Equity (ROE)	-43.49%
Return on Assets (ROA)	-0.09%
Return on Invested Capital (ROIC)	-0.14%
Return on Capital Employed (ROCE)	-0.22%
Revenue Per Employee	27,619
Profits Per Employee	-3,538
Employee Count	110,000
Asset Turnover	0.90
Inventory Turnover	6.87

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -31.47% in the last 52 weeks. The beta is 1.29, so CBDBY's price volatility has been higher than the market average.

Beta (5Y)	1.29
52-Week Price Change	-31.47%
50-Day Moving Average	0.41
200-Day Moving Average	0.45
Relative Strength Index (RSI)	55.50
Average Volume (20 Days)	11,022

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CBDBY had revenue of 3.04 billion and -389.17 million in losses. Loss per share was -0.87.

Revenue	3.04B
Gross Profit	836.23M
Operating Income	-4.85M
Pretax Income	-271.14M
Net Income	-389.17M
EBITDA	60.31M
EBIT	-4.85M
Loss Per Share	-0.87

Full Income Statement

Balance Sheet

The company has 427.82 million in cash and 1.38 billion in debt, giving a net cash position of -951.19 million.

Cash & Cash Equivalents	427.82M
Total Debt	1.38B
Net Cash	-951.19M
Net Cash Per Share	n/a
Equity (Book Value)	474.54M
Book Value Per Share	0.97
Working Capital	-38.80M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 220.38 million and capital expenditures -98.30 million, giving a free cash flow of 122.07 million.

Operating Cash Flow	220.38M
Capital Expenditures	-98.30M
Free Cash Flow	122.07M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 27.53%, with operating and profit margins of -0.16% and -12.81%.

Gross Margin	27.53%
Operating Margin	-0.16%
Pretax Margin	-8.92%
Profit Margin	-12.81%
EBITDA Margin	1.99%
EBIT Margin	-0.16%
FCF Margin	4.02%

Dividends & Yields

CBDBY does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-65.19%
Shareholder Yield	-65.19%
Earnings Yield	-168.43%
FCF Yield	52.83%

Dividend Details

Stock Splits

The last stock split was on October 18, 2010. It was a forward split with a ratio of 2.

Last Split Date	Oct 18, 2010
Split Type	Forward
Split Ratio	2

Scores

CBDBY has an Altman Z-Score of 1.02. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.02
Piotroski F-Score	n/a